Patients diagnosed with gastric adenomas or early gastric cancer were randomly divided into either the LS group ( 30mg once daily for 4 weeks ; n = 45 ) or the LS+ES group ( LS 30mg once daily for one week followed byES 1500mg twice daily for 3 weeks ; n = 45 ) .